LLY

911.36

-1.01%↓

UNH

597.64

+0.96%↑

NVO

117.53

+0.34%↑

JNJ

160.64

-0.12%↓

ABBV

194.4

-0.21%↓

LLY

911.36

-1.01%↓

UNH

597.64

+0.96%↑

NVO

117.53

+0.34%↑

JNJ

160.64

-0.12%↓

ABBV

194.4

-0.21%↓

LLY

911.36

-1.01%↓

UNH

597.64

+0.96%↑

NVO

117.53

+0.34%↑

JNJ

160.64

-0.12%↓

ABBV

194.4

-0.21%↓

LLY

911.36

-1.01%↓

UNH

597.64

+0.96%↑

NVO

117.53

+0.34%↑

JNJ

160.64

-0.12%↓

ABBV

194.4

-0.21%↓

LLY

911.36

-1.01%↓

UNH

597.64

+0.96%↑

NVO

117.53

+0.34%↑

JNJ

160.64

-0.12%↓

ABBV

194.4

-0.21%↓

Kodu・Aktsiate loetelu・Amarin Corp PLC ADR

Amarin Corp PLC ADR

Suletud

0.58 1.75

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.56

Max

0.59

Põhinäitajad
By Trading Economics
Sissetulek	11M 1.5M
Müük	11M 67M
Aktsiakasum	0.01
Kasumimarginaal	2.252
EBITDA	13M 237K

Soovitused
By TipRanks
Soovitused	Müü
12 kuu keskmine prognoos	+72.41 upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	30. okt 2024

Turustatistika
By TradingEconomics
Turukapital	6.6M 255M
Eelmine avamishind	-1.17
Eelmine sulgemishind	0.58

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

0.5725 / 0.6042 Toetus ja vastupanu

Amarin Corp PLC ADR Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

9. okt 2024, 20:37 UTC

Omandamised, ülevõtmised, äriostud

Bernard Arnault's Family to Buy Majority Stake in Paris FC, Bloomberg Reports

9. okt 2024, 19:04 UTC

Omandamised, ülevõtmised, äriostud

BlackRock Exploring Purchase of HPS Investment Partners, Bloomberg Reports

9. okt 2024, 23:52 UTC

Peamised uudised

McDonald's Is Bringing Chicken to the Big Mac -- WSJ

9. okt 2024, 23:41 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Rio Tinto's Deal for Arcadium Lithium Appears to 'Overpay for Synergies' -- Market Talk

9. okt 2024, 23:33 UTC

Peamised uudised

TD Bank Faces $3 Billion in Penalties and Growth Restrictions in U.S. Settlement -- WSJ

9. okt 2024, 22:26 UTC

Market Talk

BHP Poised for Mixed Quarterly Update -- Market Talk

9. okt 2024, 21:55 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Arcadium Lithium Shareholders Likely to Back Takeover Offer -- Market Talk

9. okt 2024, 21:48 UTC

Peamised uudised

DJT Stock Drops as Musk-Powered Trump Media Rally Loses Steam -- Barrons.com

9. okt 2024, 21:47 UTC

Peamised uudised

Trump Pledges to End 'Double Taxation' of Americans Abroad -- WSJ

9. okt 2024, 21:07 UTC

Peamised uudised

Dow, S&P 500 Rise to Records; Oil Prices Slip -- WSJ

9. okt 2024, 20:54 UTC

Peamised uudised

Delta Earnings Are Coming. Watch Out for a CrowdStrike Update. -- Barrons.com

9. okt 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

9. okt 2024, 20:50 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Basic Materials Roundup: Market Talk

9. okt 2024, 20:48 UTC

Peamised uudised

Hurricane Milton Might Distort Economic Data. GDP Could Take a Hit. -- Barrons.com

9. okt 2024, 20:14 UTC

Peamised uudised

Dow Gains; Oil Prices Slip -- WSJ

9. okt 2024, 20:00 UTC

Peamised uudised

Omandamised, ülevõtmised, äriostud

Home Depot Is Dropping Warehouses in a Shifting Retail Market -- WSJ

9. okt 2024, 19:42 UTC

Tulu

Why Google Breakup Talk Isn't Slamming Alphabet Stock -- Barrons.com

9. okt 2024, 19:34 UTC

Market Talk

McDonald's $5 Menu Key to U.S. Sales Recovery -- Market Talk

9. okt 2024, 19:30 UTC

Peamised uudised

Fed Minutes Reveal Divide Over Size of September Rate Cut -- 4th Update

9. okt 2024, 19:19 UTC

Market Talk

Starbucks Loses Some Infrequent Customers -- Market Talk

9. okt 2024, 19:08 UTC

Market Talk

Crude Oil Futures Add to Losses -- Market Talk

9. okt 2024, 19:02 UTC

Market Talk

U.S. Natural Gas Futures Falls as Major Storm Nears Florida -- Market Talk

9. okt 2024, 18:47 UTC

Market Talk

Gold Falls for Fourth Straight Session -- Market Talk

9. okt 2024, 18:39 UTC

Peamised uudised

S&P and Dow Gain; Oil Prices Slip -- WSJ

9. okt 2024, 18:13 UTC

Peamised uudised

Fed Minutes Reveal Divide Over Size of September Rate Cut -- 3rd Update

9. okt 2024, 18:10 UTC

Peamised uudised

Fed Minutes Reveal Divide Over Size of September Rate Cut -- 2nd Update

9. okt 2024, 18:08 UTC

Peamised uudised

Fed Minutes Reveal Divide Over Size of September Rate Cut -- Update

9. okt 2024, 18:07 UTC

Market Talk

US Dividend Growth Slows In 3Q Versus Year-Ago Period -- Market Talk

9. okt 2024, 18:07 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9. okt 2024, 18:04 UTC

Peamised uudised

Fed Minutes Reveal Divide Over Size of September Rate Cut -- WSJ

Võrdlus sarnastega

Hinnamuutus

Amarin Corp PLC ADR Prognoos

Hinnasiht

By TipRanks

72.41% tõus

12 kuu keskmine prognoos

Keskmine 1 USD 72.41%

Kõrge 1 USD

Madal 1 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Amarin Corp PLC ADR 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Müü

2 ratings

Osta

Hoia

Müü

Põhineb 2 analüütiku instrumendi Amarin Corp PLC ADR aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.5725 / 0.6042Toetus ja vastupanu

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Amarin Corp PLC ADR

Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company's lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.